13F
← All fund report cards

PARADIGM CAPITAL MANAGEMENT INC/NY

13F equity value
$2.6B
Positions
112
Top 10 concentration
61.5%
Quarters / total new picks
31 / 153
13F equity value over time
$0M$1B$3B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 31 quarters, returned +0.3% per quarter — versus +2.5% per quarter from simply owning every 13F stock. It beat that baseline in only 41.9% of quarters (excess t = -0.58, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-2.0%
t-stat
-0.58
Quarterly win rate
42%
Annualized excess
-14.1%
$1 → follow vs universe
$0.64 vs $1.89
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200930: universe 1.34420201231: universe 1.40520210331: universe 1.41820210630: universe 1.53120210930: universe 1.37520211231: universe 1.17020220331: universe 1.25620220630: universe 1.16420220930: universe 1.25020221231: universe 1.16120230331: universe 1.22320230630: universe 1.17920230930: universe 1.33920231231: universe 1.39820240331: universe 1.43020240630: universe 1.56020240930: universe 1.54620241231: universe 1.44320250331: universe 1.57320250630: universe 1.62320250930: universe 1.82520251231: universe 1.888 20180331: follow 1.00720180630: follow 0.71220180930: follow 0.92520181231: follow 0.76320190331: follow 0.66220190630: follow 0.85020190930: follow 0.95120191231: follow 0.86820200331: follow 1.13520200930: follow 1.54920201231: follow 1.53420210331: follow 1.48120210630: follow 1.53320210930: follow 1.39720211231: follow 1.16320220331: follow 1.10520220630: follow 0.85120220930: follow 0.99120221231: follow 0.87120230331: follow 0.79620230630: follow 0.77220230930: follow 0.92820231231: follow 0.86920240331: follow 1.13020240630: follow 1.17420240930: follow 1.22220241231: follow 1.04520250331: follow 1.16620250630: follow 0.86220250930: follow 0.96820251231: follow 0.642 0.59 1.31 2.04 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 112 · 2026 Q1

Ticker Value Weight QoQ
MOD $315M
12.1%
HOLD
FN $277M
10.6%
HOLD
AVGO $250M
9.6%
HOLD
ONTO $226M
8.6%
TRIM
JBL $146M
5.6%
HOLD
DCO $94M
3.6%
HOLD
EXTR $79M
3.0%
ADD
ENS $77M
2.9%
TRIM
VECO $74M
2.8%
TRIM
GMED $71M
2.7%
TRIM
ENSG $69M
2.6%
HOLD
NSIT $64M
2.5%
ADD
ENTG $61M
2.4%
HOLD
NVRI $44M
1.7%
TRIM
PNTG $43M
1.6%
HOLD
ENOV $40M
1.6%
ADD
OFIX $38M
1.5%
HOLD
UCTT $38M
1.5%
HOLD
IART $38M
1.5%
ADD
CALX $38M
1.4%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

None.

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.